<DOC>
	<DOC>NCT02901275</DOC>
	<brief_summary>This research is being done to evaluate whether combining medications that are FDA approved but have not yet been approved for combination treatment, can be an effective way to reduce pain.</brief_summary>
	<brief_title>Enhancing Medication-based Analgesia in Humans</brief_title>
	<detailed_description>This study will systematically evaluate whether a combination of pharmacotherapies can effectively alleviate chronic pain. Subjects will complete two screening sessions before completing 6 study sessions that will occur once weekly. Subjects will double-blind doses of study medications the morning of each experimental session, and will undergo standardized pain testing, as well as provide self-report ratings of drug effects, and cognitive tests.</detailed_description>
	<criteria>Not pregnant or breast feeding Medically cleared to take blinded study medications Willing to comply with study protocol Not experiencing and/or being treated for current pain Lack of significant medical or psychiatric illness that would interfere with study participation or informed consent Known allergy to the blinded study medications</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Clinical Trial, Phase II</keyword>
	<keyword>Analgesia</keyword>
</DOC>